Table 1.

Demographic and neuropathological characteristics by presence or absence of diffuse and neuritic plaques

	DPs Present	DPs Absent	NPs Present	NPs Absent	NPs and DPs Present	NPs and DPs Absent
N	79	44	77	46	72	39
Gender (M/F)	36/43	27/17	33/44	30/16	31/41	25/14
APOE ε4 (carrier/non-carrier)	17/61	4/40	18/59	3/42	17/55	3/36
Age at Death (y)	85.74±5.09	80.58±6.46	85.51±5.23	81.19±6.58	85.71±5.24	80.21±6.50
Education (y)	18.29±3.27	18.30±4.13	18.23±3.40	18.39±3.92	18.33±3.31	18.36±4.04
MMSE	28.19±1.33	28.48±1.42	28.22±1.34	28.41±1.41	28.26±1.30	28.46±1.36
PMI (h)	7.61±8.37	7.55±5.31	7.35±8.44	7.97±5.29	7.58±8.80	7.81±5.45
Brain Weight (g)	1,230.71±145.69	1,251.14±156.03	1,227.37±152.04	1,255.87±143.94	1,224.55±148.58	1,254.97±153.10
LCA and Death (y)	0.77±0.93	0.66±0.44	0.76±0.95	0.68±0.43	0.81±0.98	0.68±0.45
Braak Stage
0	1	2	0	3	0	2
I	8	12	6	14	5	12
II	14	8	12	10	12	8
III	22	13	23	12	21	11
IV	29	9	31	7	27	6
V	5	0	5	0	5	0

DPs, diffuse plaques; LCA, Last clinical assessment; NPs, neuritic plaques; PMI, postmortem interval.